ECFI Medicinal products for human use – Marketing authorisation for the medicinal product Orphacol – Letter informing the applicant of the Commission’s intention to refuse authorisation – Application for a declaration of failure to act – Definition of position by the Commission – Inadmissibility – Application for annulment – Adoption of a new decision – No need to adjudicate
Judges:
S. Papasavvas, P
Citations:
T-12/12, [2012] EUECJ T-12/12
Links:
Jurisdiction:
European
Health, Licensing
Updated: 04 November 2022; Ref: scu.463236